Logo image
Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses
Journal article   Open access   Peer reviewed

Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses

Richard J Connolly, Taryn Chapman, Andrew M Hoff, Michele A Kutzler, Mark J Jaroszeski and Kenneth E Ugen
Human vaccines & immunotherapeutics, v 8(11), pp 1729-1733
01 Nov 2012
PMID: 22894954
url
https://doi.org/10.4161/hv.21624View
Published, Version of Record (VoR) Open

Abstract

T-Lymphocytes, Cytotoxic - immunology Immunity, Cellular - immunology Animals Enzyme-Linked Immunosorbent Assay Immunity, Humoral - immunology Vaccines, DNA - immunology Female Mice Mice, Inbred BALB C Helium Vaccines, DNA - administration & dosage
Non-viral in vivo administration of plasmid DNA for vaccines and immunotherapeutics has been hampered by inefficient delivery. Methods to enhance delivery such as in vivo electroporation (EP) have demonstrated effectiveness in circumventing this difficulty. However, the contact-dependent nature of EP has resulting side effects in animals and humans. Noncontact delivery methods should, in principle, overcome some of these obstacles. This report describes a helium plasma-based delivery system that enhanced humoral and cellular antigen-specific immune responses in mice against an intradermally administered HIV gp120-expressing plasmid vaccine (pJRFLgp120). The most efficient plasma delivery parameters investigated resulted in the generation of geometric mean antibody-binding titers that were 19-fold higher than plasmid delivery alone. Plasma mediated delivery of pJRFLgp120 also resulted in a 17-fold increase in the number of interferon-gamma spot-forming cells, a measure of CD8+ cytotoxic T cells, compared with non-facilitated plasmid delivery. This is the first report demonstrating the ability of this contact-independent delivery method to enhance antigen-specific immune responses against a protein generated by a DNA vaccine.

Metrics

6 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biotechnology & Applied Microbiology
Immunology
Logo image